BPC-157 TB-500 10mg Peptide — Premium Research Blend (Wolverine Stack)
The BPC-157 TB-500 10mg peptide blend from Astra Labs is a premium
lyophilised research compound combining two of the most extensively discussed peptides in
research literature. Each sterile vial contains a total of 10mg — comprising
5mg BPC-157 and 5mg TB-500 — supplied for laboratory research use only.
Commonly referred to as the Wolverine Stack or Wolverine Blend across
the research community, this combination allows researchers to investigate both compounds
simultaneously in a single controlled preparation. Furthermore, the lyophilised format
ensures long-term stability during storage and transport.
Every batch of Astra Labs BPC-157 TB-500 10mg peptide is independently third-party tested
by Janoshik Analytical. As a result, buyers can verify compound identity and
purity directly through the linked Certificate of Analysis before purchasing.
✓ Janoshik Verified COA
Independent third-party testing for compound
identity, purity and quality. Click below to verify this batch directly on the Janoshik
platform.
BPC-157 TB-500 10mg Peptide — Product Specifications
| Specification | Detail |
|---|---|
| Product | BPC-157 + TB-500 10mg peptide blend |
| Common name | Wolverine Stack / Wolverine Blend |
| Total quantity | 10mg per vial |
| BPC-157 content | 5mg |
| TB-500 content | 5mg (Thymosin Beta-4 fragment) |
| Format | Lyophilised powder |
| Packaging | Sterile sealed glass vial |
| Purity | High-purity research grade |
| COA | ✅ Janoshik third-party verified |
| Dispatch | UK domestic — fast |
| Use | Laboratory research only |
What Is the Wolverine Stack?
The Wolverine Stack is the informal community name for a combined
BPC-157 and TB-500 research peptide blend. The pairing reflects how frequently these two
compounds appear together in research literature. Therefore, supplying them in a single vial
allows for streamlined research handling — particularly useful in tissue and cellular
signalling pathway investigations.
About the Compounds
- BPC-157 — a synthetic 15-amino-acid peptide (pentadecapeptide) derived
from a protein found in human gastric juice. It is widely studied in tissue and recovery
research contexts. - TB-500 — a synthetic fragment of Thymosin Beta-4, a naturally occurring
protein originally isolated from the thymus gland. Frequently studied in cellular signalling
pathway research.
Both compounds are supplied strictly as research-use-only materials. Neither is approved
for human consumption or therapeutic use in the UK.
Storage and Handling
- Store BPC-157 TB-500 10mg peptide in a cool, dry place at 2–8°C
- Keep away from direct sunlight and heat
- Refrigerate after reconstitution
- Avoid repeated freeze and thaw cycles
- Use sterile technique when handling the lyophilised compound
- Original sealed vial recommended for long-term storage stability
Why Choose Astra Labs BPC-157 TB-500 10mg Peptide?
- ✅ Janoshik third-party COA — independent purity verification
- ✅ UK-based dispatch — no customs delays, no overseas handling
- ✅ Discreet packaging — unmarked, professional delivery
- ✅ Secure checkout — fully encrypted at every stage
- ✅ Balanced 5mg + 5mg formulation — equal compound ratio
- ✅ Lyophilised stability — long shelf life in original format
- ✅ UK-registered company — verifiable via Companies House
- ✅ Research-use-only compliance — no medical claims
Frequently Asked Questions — BPC-157 TB-500 10mg Peptide
What is the BPC-157 TB-500 10mg peptide blend?
The BPC-157 TB-500 10mg peptide blend is a combined research peptide
vial containing 5mg BPC-157 and 5mg TB-500 (Thymosin Beta-4 fragment) in lyophilised form.
It is commonly known as the Wolverine Stack and is supplied by Astra Labs strictly for
laboratory research use only.
Does the BPC-157 TB-500 10mg peptide come with a COA?
Yes. Every Astra Labs BPC-157 TB-500 10mg peptide vial is supplied
with a Janoshik third-party Certificate of Analysis. The COA links directly from this
product page to the Janoshik verification platform for independent confirmation of
compound identity and purity.
How is BPC-157 TB-500 10mg peptide stored?
Store the lyophilised BPC-157 TB-500 10mg peptide in a cool dry place
at 2–8°C, away from direct sunlight and heat. After reconstitution, refrigeration is
recommended. Avoid repeated freeze and thaw cycles to maintain compound stability.
Is BPC-157 TB-500 10mg peptide legal in the UK?
Yes. Neither BPC-157 nor TB-500 is a controlled substance in the UK.
The blend can be legally supplied for laboratory research purposes only. However, it is
not MHRA-approved and cannot be used for human consumption, therapeutic use or medical
application.
What is the Wolverine Stack?
The Wolverine Stack is the informal community name for a combined
BPC-157 and TB-500 research peptide blend. Astra Labs supplies the Wolverine Stack as
a 10mg vial containing 5mg BPC-157 and 5mg TB-500.
How quickly is BPC-157 TB-500 10mg peptide dispatched?
Astra Labs dispatches BPC-157 TB-500 10mg peptide quickly from UK
stock. Because all stock is held domestically, delivery is significantly faster than
overseas suppliers. Discreet packaging and fully secured checkout apply to every order.
Research Use Information
BPC-157 TB-500 10mg peptide is supplied strictly for laboratory research purposes only.
It is not intended for human consumption, therapeutic use, or medical application. Researchers
should ensure all handling and use complies with relevant laboratory guidelines and standards.
For broader scientific reading on the compounds, researchers can explore peer-reviewed
publications on
PubMed BPC-157
and
PubMed Thymosin Beta-4.
Related Pages and Resources
- Buy BPC-157 TB-500 UK — Full Buyer’s Guide
- All Astra Labs Certificates of Analysis
- Research Peptides UK — Full Range
- Buy Peptides UK — Supplier Guide
- Are Peptides Legal in the UK? (2026)
- Best Peptide Supplier UK 2026
- What Are Peptides? — Beginner Guide
Important: This product is intended strictly for laboratory research use only.
Not for human consumption, therapeutic use, or medical application. For UK medicines regulation,
refer to the
MHRA.
